Sifei Xing

发表

Targeting HIV latency: pharmacologic strategies toward eradication.

R. Siliciano, Sifei Xing, 2013, Drug discovery today.

The HBV drug entecavir - effects on HIV-1 replication and resistance.

Lin Shen, Yan Zhou, Jun O. Liu, 2007, The New England journal of medicine.

A Critical Subset Model Provides a Conceptual Basis for the High Antiviral Activity of Major HIV Drugs

R. Siliciano, A. Sedaghat, J. Lai, 2011, Science Translational Medicine.

Transcriptional Reprogramming during Effector‐to‐Memory Transition Renders CD4+ T Cells Permissive for Latent HIV‐1 Infection

R. Siliciano, J. Margolick, J. Siliciano, 2017, Immunity.

An In-Depth Comparison of Latent HIV-1 Reactivation in Multiple Cell Model Systems and Resting CD4+ T Cells from Aviremic Patients

Eric Verdin, Celsa A. Spina, Alberto Bosque, 2013, PLoS pathogens.

BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism

R. Siliciano, R. D. Dar, L. Weinberger, 2013, Cell cycle.

Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation.

Hao Zhang, Yan Zhou, Karen O'Connell, 2009, The Journal of clinical investigation.

Disulfiram Reactivates Latent HIV-1 in a Bcl-2-Transduced Primary CD4+ T Cell Model without Inducing Global T Cell Activation

R. Siliciano, J. Margolick, T. Quinn, 2011, Journal of Virology.

Unique characteristics of histone deacetylase inhibitors in reactivation of latent HIV-1 in Bcl-2-transduced primary resting CD4+ T cells.

R. Siliciano, J. Margolick, Hung‐Chih Yang, 2014, The Journal of antimicrobial chemotherapy.

Novel structurally related compounds reactivate latent HIV-1 in a bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation

Jun O. Liu, R. Siliciano, J. Margolick, 2011, The Journal of antimicrobial chemotherapy.

Unique characteristics of histone deacetylase inhibitors in reactivation of latent HIV-1 in Bcl-2-transduced primary resting CD4+ T cells.

R. Siliciano, J. Margolick, Hung‐Chih Yang, 2014, The Journal of antimicrobial chemotherapy.

Disulfiram Reactivates Latent HIV-1 in a Bcl-2-Transduced Primary CD4+ T Cell Model without Inducing Global T Cell Activation

R. Siliciano, J. Margolick, T. Quinn, 2011, Journal of Virology.

Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation.

Jun O. Liu, R. Siliciano, H. Zhang, 2009, The Journal of clinical investigation.

The HBV drug entecavir - effects on HIV-1 replication and resistance.

Jun O. Liu, R. Siliciano, C. Chong, 2007, The New England journal of medicine.

Lin Shen Antiviral Activity of Major HIV Drugs A Critical Subset Model Provides a Conceptual Basis for the High

R. Siliciano, A. Sedaghat, J. Lai, 2011 .